Inhibition of amylin with insulin B chain derived peptides (alanine scan)
Inhibition was measured using the ThT fluorescence assay as described in the materials and methods. Human amylin (Calbiochem Inc., CA, USA) was dissolved in HFIP to produce a 400 m stock solution. The stock solution was then distributed into solutions containing 40 m inhibiting peptides (Peptron Inc., Taejeon, Korea) in 10 mM sodium acetate buffer pH 6.5 (10-fold excess for inhibiting peptides), or into 10 mM sodium acetate buffer alone to a final concentration of 4 M. Immediately after dilution, the samples were centrifuged for 15 min at 20K rcf at 4 ºC, and the pellet was removed.
Aliquots of the reaction solutions were diluted 10-fold into a sodium acetate buffer with 0.03 M ThT. Fluorescence values were measured immediately after preparation and after different incubation periods, at excitation of 450 nm and an emission of 480 nm, using a Jobin Yvon Horiba Fluoromax 3 fluorimeter. The experiment was performed with three independent repeats. Average values are presented, bars (in column graph) indicating the standard deviations.
Construction of models of insulin-amylin aggregates
Four polymorphic models of amylin hexamers which previously studied by our group 1 were constructed. Figure S1 illustrates these four structural of models of amylin aggregates (M1-M4). These four models illustrate single layer conformations. The experimental structural models of amylin demonstrate double layer conformations, i.e. "protofilaments". 2, 3 The current work focuses only on the single layer conformations.
The C-termini of the amylin monomers within the fibrillary structures are nonamidated. Experimental studies showed that the non-amidated at the C-terminal of amylin are known to aggregate slower than the amidated amylin. 4 Herein, we do not investigate the kinetics of amylin aggregation.
The insulin molecule that has been applied in the current study was taken from the crystal structure, pdb id code: 1GUJ. 5 Sixteen different models of insulin-amylin aggregates were constructed. In each model an insulin molecule (pdb id code: 1GUJ) 5 interacts with each one of the four polymorphic structural amylin hexamers. 1 In the current work, interactions of insulin with double layer conformations have not been investigated. In the case where insulin interacts with the N-termini of amylin's fibrillary domains, one can expect that similar scenario and effects that are seen in the amylin single layer conformations will be obtained also in the double layer conformations. However, in the case in which insulin interacts with the C-termini of amylin's fibrillary domains in the single layer conformations, insulin cannot interact in the double layer conformation. Therefore, the later case cannot be examined in the double layer conformations.
The binding site recognition domain in which an insulin molecule interacts with amylin peptides have been proposed by two experimental studies. One study suggested that the central domain of insulin B chain (residues 9-20) binds to the first β-strand domain in amylin (residues 7-19). 6 The second study proposed that the C-terminal of insulin B chain (residues 22-29) bind to the second β-strand domain in amylin (residues 23-30). 7 Each one of these two propose recognition domains was examined for each one of the four polymorphic amylin aggregates while binding to the central monomer along the fibrillary structure of amylin aggregate in two different orientations within the recognition domains (as illustrated schematically in Figures S2 and S3 ).
In Figure S2 , insulin chain B (residue 9-20) interact with amylin aggregate in two different orientations within the recognition domain in amylin aggregate: the first orientation is with residues 7-19, and the second with residues 19-7. We modeled eight constructed models of insulin-amylin aggregates: models A1-A4 ( Figure S4 ) and B1-B4 ( Figure S5 ).
In Figure S3 , insulin chain B (residue 22-29) interact with amylin aggregate in two different orientations within the recognition domain in amylin aggregate: the first orientation is with residues 23-30, and the second with residues 30-23. We modeled eight constructed models of insulin-amylin aggregates: models C1-C4 ( Figure S6 ) and D1-D4 ( Figure S7 ). It should be noted, that in mode D1 the insulin was escaped from the amylin aggregate during the molecular dynamics (MD) simulations, therefore this model is neglected in this framework.
Finally, mutations of Y16 to A16 in insulin molecule were performed for models A1 and B1, using the original initial constructed models -producing models P1 and Q1, respectively.
Determining the Conformational Energies and Populations for the Simulated

Models of Insulin-Amylin Aggregates
To obtain the relative structural stability of the variant models, the trajectories of the last 5 ns were first extracted from the explicit MD simulation excluding water molecules. The solvation energies of all systems were calculated using the Generalized Born Method with Molecular Volume (GBMV). 8, 9 In the GBMV calculations, the dielectric constant of water was set to 80.0. The hydrophobic solvent-accessible surface area (SASA) term factor was set to 0.00592 kcal/mol•Å 2 . Each variant is minimized 1000 cycles and the conformation energy is evaluated by grid-based GBMV. The minimization does not change the conformations of each variant, but only relaxed the local geometries due to thermal fluctuation which occurred during the MD simulations.
A total of 8,000 conformations (500 conformations for each of the 16 examined conformers) were used to construct the free energy landscape of the conformers and to evaluate the conformer probabilities by using Monte Carlo (MC) simulations. In the first step, one conformation of conformer i and one conformation of conformer j were randomly selected. Then, the Boltzmann factor was computed as e-(Ej-Ei)/kT, where Ei and Ej are the conformational energies evaluated using the GBMV calculations for conformations i and j, respectively, k is the Boltzmann constant and T is the absolute temperature (298 K used here). If the value of the Boltzmann factor was larger than the random number, then the move from conformation i to conformation j was allowed.
After 1 million steps, the conformations 'visited' for each conformer were counted.
Finally, the relative probability of model n was evaluated as Pn= Nn/Ntotal, where Pn is the population of model n, Nn is the total number of conformations visited for model n, and Ntotal is the total steps. The advantages of using MC simulations to estimate conformer probability lie in their good numerical stability and the control that they allow of transition probabilities among several conformers .
Using all twelve models and 8,000 conformations (500 for each model) generated from the MD simulations, we estimated the overall stability and populations for each conformer based on the MD simulations, with the energy landscape being computed with GBMV for these twelve models. The group of these twelve models is likely to present may be only a very small percentage of the ensemble. Nevertheless, the carefully selected models cover the most likely structures.
To validate the choice of the statistical calculations of 500 conformations for each model, we applied also statistical calculations of 1000 conformations from the last 10 ns for each model. One can see from Figures S22-S24 , that the energies are similar and the relative conformational energies illustrate similar trends.
Determining hydrophobic, electrostatic and π-π interactions
The hydrophobic interactions between two residues were estimated by measurements of the distances between Cα atoms of two residues. The cutoff distance for hydrophobic interactions is 10 Å. 10 The electrostatic interactions between two residues were estimated by the distance measurements between O atom of the acidic residue and the N atom of the base residue. The cutoff distance for electrostatic interactions is 4 Å. 11 The cutoff distance between C atom of two aromatic residue that estimated the π-π interactions is 7 Å. 12 The specific C atoms of the aromatic residues of each model are summarized in Table S1 . Figure S7 . In model D1, the insulin has been escaped from the amylin aggregate, breaking the insulin-amylin aggregate complex. .   Table S1 : The C atoms in the aromatic residues in which the distances between them were measured in order to estimate the π-π interactions between amylin aggregates and insulin B chain (IBC) for wild-type insulin-amylin aggregate models A1, B1 and for models P1 and Q1, in which the Tyr16 in IBC was mutated in Ala.
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